Skip to content

Author

Roy S. Herbst

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Looking back on the history of epidermal growth factor receptor mutations in lung cancer.

Despite ongoing challenges owing to drug resistance, novel therapeutic strategies and rational drug combinations continue to redefine the treatment landscape, such that the treatment of EGFR-driven lung cancer remains a paradigm for the application of precision medicine to cancer.

Roy S. Herbst, Meina Wang, Katerina Politi · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.